PortalPublikationenFour-week prevalence of mental disorders in patients with ca...

Four-week prevalence of mental disorders in patients with cancer across major tumor entities

Standard

Four-week prevalence of mental disorders in patients with cancer across major tumor entities. / Mehnert, Anja; Brähler, Elmar; Faller, Hermann; Härter, Martin; Keller, Monika; Schulz, Holger; Wegscheider, Karl; Weis, Joachim; Boehncke, Anna; Hund, Bianca; Reuter, Katrin; Richard, Matthias; Sehner, Susanne; Sommerfeldt, Sabine; Szalai, Carina; Wittchen, Hans-Ulrich; Koch-Gromus, Uwe.

in: J CLIN ONCOL, Jahrgang 32, Nr. 31, 01.11.2014, S. 3540-6.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Mehnert, A, Brähler, E, Faller, H, Härter, M, Keller, M, Schulz, H, Wegscheider, K, Weis, J, Boehncke, A, Hund, B, Reuter, K, Richard, M, Sehner, S, Sommerfeldt, S, Szalai, C, Wittchen, H-U & Koch-Gromus, U 2014, 'Four-week prevalence of mental disorders in patients with cancer across major tumor entities', J CLIN ONCOL, Jg. 32, Nr. 31, S. 3540-6. https://doi.org/10.1200/JCO.2014.56.0086

APA

Mehnert, A., Brähler, E., Faller, H., Härter, M., Keller, M., Schulz, H., Wegscheider, K., Weis, J., Boehncke, A., Hund, B., Reuter, K., Richard, M., Sehner, S., Sommerfeldt, S., Szalai, C., Wittchen, H-U., & Koch-Gromus, U. (2014). Four-week prevalence of mental disorders in patients with cancer across major tumor entities. J CLIN ONCOL, 32(31), 3540-6. https://doi.org/10.1200/JCO.2014.56.0086

Vancouver

Mehnert A, Brähler E, Faller H, Härter M, Keller M, Schulz H et al. Four-week prevalence of mental disorders in patients with cancer across major tumor entities. J CLIN ONCOL. 2014 Nov 1;32(31):3540-6. https://doi.org/10.1200/JCO.2014.56.0086

Bibtex

@article{030e5d62e5034f4ebbb0d0a996619da5,
title = "Four-week prevalence of mental disorders in patients with cancer across major tumor entities",
abstract = "PURPOSE: To provide the 4-week prevalence estimates of mental disorders in cancer populations.PATIENTS AND METHODS: We enrolled adult patients with cancer from in- and outpatient care facilities, using a proportional stratified random sample based on the nationwide cancer incidence in Germany. Patients who scored 9 or above on the Patient Health Questionnaire (PHQ-9) were administered to the standardized computer-assisted Composite International Diagnostic Interview for mental disorders adapted for cancer patients (CIDI-O). A random sample of those with a PHQ-9 score that was less than 9 were selected for a CIDI-O.RESULTS: A total of 5,889 patients were identified, which led to 4,020 participants (a 68.3% response rate); of those, 2,141 patients were interviewed. The 4-week total prevalence for any mental disorder was 31.8% (95% CI, 29.8% to 33.8%); this included any anxiety disorder (11.5%; 95% CI, 10.2% to 12.9%), any adjustment disorder (11.1%; 95% CI, 9.7% to 12.4%), any mood disorder (6.5%; 95% CI, 5.5% to 7.5%), any somatoform/conversion disorder (5.3%; 95% CI, 4.3% to 6.2%), nicotine dependence (4.5%; 95% CI, 3.6% to 5.4%), alcohol abuse/dependence (0.3%; 95% CI, 0.1% to 0.6%), any mental disorder resulting from general medical condition (2.3%; 95% CI, 1.7% to 2.9%), and any eating disorder (0%). The highest prevalence for any mental disorder was found in patients with breast cancer (41.6%; 95% CI, 36.8% to 46.4%), followed by patients with head and neck cancer (40.8%; 95% CI, 28.5% to 53.0%). The lowest prevalence was found in patients with pancreatic cancer (20.3%; 95% CI, 8.9% to 31.6%) and stomach/esophagus cancers (21.2%; 95% CI, 12.8% to 29.6%).CONCLUSION: Our findings provide evidence for the strong need for psycho-oncological interventions.",
keywords = "Cross-Sectional Studies, Female, Germany, Humans, Male, Mental Disorders, Middle Aged, Neoplasms, Prevalence, Questionnaires",
author = "Anja Mehnert and Elmar Br{\"a}hler and Hermann Faller and Martin H{\"a}rter and Monika Keller and Holger Schulz and Karl Wegscheider and Joachim Weis and Anna Boehncke and Bianca Hund and Katrin Reuter and Matthias Richard and Susanne Sehner and Sabine Sommerfeldt and Carina Szalai and Hans-Ulrich Wittchen and Uwe Koch-Gromus",
note = "{\textcopyright} 2014 by American Society of Clinical Oncology.",
year = "2014",
month = nov,
day = "1",
doi = "10.1200/JCO.2014.56.0086",
language = "English",
volume = "32",
pages = "3540--6",
journal = "J CLIN ONCOL",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "31",

}

RIS

TY - JOUR

T1 - Four-week prevalence of mental disorders in patients with cancer across major tumor entities

AU - Mehnert, Anja

AU - Brähler, Elmar

AU - Faller, Hermann

AU - Härter, Martin

AU - Keller, Monika

AU - Schulz, Holger

AU - Wegscheider, Karl

AU - Weis, Joachim

AU - Boehncke, Anna

AU - Hund, Bianca

AU - Reuter, Katrin

AU - Richard, Matthias

AU - Sehner, Susanne

AU - Sommerfeldt, Sabine

AU - Szalai, Carina

AU - Wittchen, Hans-Ulrich

AU - Koch-Gromus, Uwe

N1 - © 2014 by American Society of Clinical Oncology.

PY - 2014/11/1

Y1 - 2014/11/1

N2 - PURPOSE: To provide the 4-week prevalence estimates of mental disorders in cancer populations.PATIENTS AND METHODS: We enrolled adult patients with cancer from in- and outpatient care facilities, using a proportional stratified random sample based on the nationwide cancer incidence in Germany. Patients who scored 9 or above on the Patient Health Questionnaire (PHQ-9) were administered to the standardized computer-assisted Composite International Diagnostic Interview for mental disorders adapted for cancer patients (CIDI-O). A random sample of those with a PHQ-9 score that was less than 9 were selected for a CIDI-O.RESULTS: A total of 5,889 patients were identified, which led to 4,020 participants (a 68.3% response rate); of those, 2,141 patients were interviewed. The 4-week total prevalence for any mental disorder was 31.8% (95% CI, 29.8% to 33.8%); this included any anxiety disorder (11.5%; 95% CI, 10.2% to 12.9%), any adjustment disorder (11.1%; 95% CI, 9.7% to 12.4%), any mood disorder (6.5%; 95% CI, 5.5% to 7.5%), any somatoform/conversion disorder (5.3%; 95% CI, 4.3% to 6.2%), nicotine dependence (4.5%; 95% CI, 3.6% to 5.4%), alcohol abuse/dependence (0.3%; 95% CI, 0.1% to 0.6%), any mental disorder resulting from general medical condition (2.3%; 95% CI, 1.7% to 2.9%), and any eating disorder (0%). The highest prevalence for any mental disorder was found in patients with breast cancer (41.6%; 95% CI, 36.8% to 46.4%), followed by patients with head and neck cancer (40.8%; 95% CI, 28.5% to 53.0%). The lowest prevalence was found in patients with pancreatic cancer (20.3%; 95% CI, 8.9% to 31.6%) and stomach/esophagus cancers (21.2%; 95% CI, 12.8% to 29.6%).CONCLUSION: Our findings provide evidence for the strong need for psycho-oncological interventions.

AB - PURPOSE: To provide the 4-week prevalence estimates of mental disorders in cancer populations.PATIENTS AND METHODS: We enrolled adult patients with cancer from in- and outpatient care facilities, using a proportional stratified random sample based on the nationwide cancer incidence in Germany. Patients who scored 9 or above on the Patient Health Questionnaire (PHQ-9) were administered to the standardized computer-assisted Composite International Diagnostic Interview for mental disorders adapted for cancer patients (CIDI-O). A random sample of those with a PHQ-9 score that was less than 9 were selected for a CIDI-O.RESULTS: A total of 5,889 patients were identified, which led to 4,020 participants (a 68.3% response rate); of those, 2,141 patients were interviewed. The 4-week total prevalence for any mental disorder was 31.8% (95% CI, 29.8% to 33.8%); this included any anxiety disorder (11.5%; 95% CI, 10.2% to 12.9%), any adjustment disorder (11.1%; 95% CI, 9.7% to 12.4%), any mood disorder (6.5%; 95% CI, 5.5% to 7.5%), any somatoform/conversion disorder (5.3%; 95% CI, 4.3% to 6.2%), nicotine dependence (4.5%; 95% CI, 3.6% to 5.4%), alcohol abuse/dependence (0.3%; 95% CI, 0.1% to 0.6%), any mental disorder resulting from general medical condition (2.3%; 95% CI, 1.7% to 2.9%), and any eating disorder (0%). The highest prevalence for any mental disorder was found in patients with breast cancer (41.6%; 95% CI, 36.8% to 46.4%), followed by patients with head and neck cancer (40.8%; 95% CI, 28.5% to 53.0%). The lowest prevalence was found in patients with pancreatic cancer (20.3%; 95% CI, 8.9% to 31.6%) and stomach/esophagus cancers (21.2%; 95% CI, 12.8% to 29.6%).CONCLUSION: Our findings provide evidence for the strong need for psycho-oncological interventions.

KW - Cross-Sectional Studies

KW - Female

KW - Germany

KW - Humans

KW - Male

KW - Mental Disorders

KW - Middle Aged

KW - Neoplasms

KW - Prevalence

KW - Questionnaires

U2 - 10.1200/JCO.2014.56.0086

DO - 10.1200/JCO.2014.56.0086

M3 - SCORING: Journal article

C2 - 25287821

VL - 32

SP - 3540

EP - 3546

JO - J CLIN ONCOL

JF - J CLIN ONCOL

SN - 0732-183X

IS - 31

ER -